Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 3.120
-0.046 (-1.45%)
At close: Mar 9, 2026
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.03 billion as of March 9, 2026. Its market cap has increased by 26.14% in one year.
Market Cap
1.03B
Enterprise Value
451.80M
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.12
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.03B, a decrease of -81.28%. That is a compound annual growth rate of -23.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArcticZymes Technologies ASA | 1.16B |
| Lytix Biopharma AS | 730.55M |
| Circio Holding ASA | 717.79M |
| Thor Medical ASA | 1.53B |
| Zelluna ASA | 409.70M |
| SoftOx Solutions AS | 155.87M |
| EXACT Therapeutics AS | 110.08M |
| Arctic Bioscience AS | 91.65M |